Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00015 | 1 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -6.9e-05 | 1 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 7.2e-05 | 1 |